| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/11/1999 | CA2298573A1 Synaptojanin isoform |
| 02/11/1999 | CA2297747A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 02/11/1999 | CA2294064A1 Il-8 receptor antagonists |
| 02/11/1999 | CA2294032A1 Self-emulsifying formulation for lipophilic compounds |
| 02/11/1999 | CA2290750A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/10/1999 | EP0896061A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0896060A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0895543A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 02/10/1999 | EP0787008A4 Method for treating secondary immunodeficiency |
| 02/10/1999 | EP0710239B1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/10/1999 | CN1207743A Inhibitors of interleukin-1 'beta' converting enzyme |
| 02/10/1999 | CN1207731A 3-pyrazolecarboxamide derivs. having cannabinoid receptor affinity |
| 02/10/1999 | CN1207686A FC 'epsilon'-PE chimeric protein for targeted treatment of allergy responses, method for its production and pharmaceutical compositions contg. same |
| 02/10/1999 | CN1207675A Sublingual and buccal administration of selegiline |
| 02/10/1999 | CN1207672A Modified release oral pharmaceutical composition contg. 5-ASA and method for treatment of bowel diseases |
| 02/10/1999 | CN1207395A Anti-FAS antibodies |
| 02/10/1999 | CN1042030C Method for preparing substituted dibenzofurans |
| 02/10/1999 | CN1042026C 25 carboxylic deriv. of vitamin D series, its preparing method, middle products in production of same and medicine contg. same and pharmaceutical use of same in treatment |
| 02/09/1999 | US5869663 Intermediates for neurokinin receptor antagonists |
| 02/09/1999 | US5869636 Recombinant cell line expressing polypetide for anticarcinogenic and antitumor agents and vaccines |
| 02/09/1999 | US5869619 Modified antibody variable domains |
| 02/09/1999 | US5869603 Amino acid sequences of synthetic peptides binding to neutralizing antibodies against recombinant interferon-beta; for detection and inhibition of antibodies in patients |
| 02/09/1999 | US5869523 Protecting forskolin, deacetylating, treating with beta-halopropionyl halide, treating with alkali, acetylating, reacting with amine, deprotecting |
| 02/09/1999 | US5869515 1,3-dihydro-2H-imidazol-2-one compounds |
| 02/09/1999 | US5869511 Isoxazoline compounds as inhibitors of TNF release |
| 02/09/1999 | US5869499 Benzyloxyquinuclidines as substance P antagonists |
| 02/09/1999 | US5869486 Fused pyrimidines and pyriazines as pharmaceutical compounds |
| 02/09/1999 | US5869485 Treatment of diseases which respond to inhibition of the activity of the protein tyrosine kinase |
| 02/09/1999 | US5869475 Certain 3-ketosteroids used to inhibit steroid 5α-reductase |
| 02/09/1999 | US5869447 Cyclohexapeptides and their mixtures, a process for preparing them, and their use |
| 02/09/1999 | US5869333 Ryegrass pollen allergen |
| 02/09/1999 | US5869324 Chiral resolution by contacting mixture with enzyme and acylating agent, separating esterified calanolide a |
| 02/09/1999 | US5869286 Receptor that binds IL-17 |
| 02/09/1999 | US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/09/1999 | US5869270 Single chain MHC complexes and uses thereof |
| 02/09/1999 | US5869057 Administering a fusion protein comprising pentamers of escherichia coli labile toxin subunit b and human chorionic gonadotropin |
| 02/09/1999 | US5869050 Administering to patient antibody against b7 antigen and immunosuppressive agent in synergistic mixture; treatment of transplant rejection, graft versus host disease, rheumatoid arthritis |
| 02/09/1999 | US5869049 Methods of inducing T cell unresponsiveness to bone marrow with gp39 antagonists |
| 02/09/1999 | US5869047 Methods for therapeutically treating immunocomprised persons |
| 02/09/1999 | CA2226091C Cyclosporin-containing soft capsule preparations |
| 02/09/1999 | CA2151385C Ophthalmic compositions comprising emedastine and their use for treating allergic conjunctivitis |
| 02/09/1999 | CA2134413C Use of hydroxychloroquine for treatment of graft-versus-host disease |
| 02/08/1999 | CA2239223A1 Novel rpoa |
| 02/08/1999 | CA2239222A1 Novel rpoa |
| 02/04/1999 | WO1999005527A2 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 02/04/1999 | WO1999005175A2 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1) |
| 02/04/1999 | WO1999005174A1 The ha-1 antigen |
| 02/04/1999 | WO1999005173A1 The ha-1 antigen |
| 02/04/1999 | WO1999005113A1 Substituted 6-phenylphenanthridines |
| 02/04/1999 | WO1999005112A1 Substituted 6-alkylphenanthridines |
| 02/04/1999 | WO1999005111A1 Novel tetrazole derivatives |
| 02/04/1999 | WO1999005107A1 Vitronectin receptor antagonist |
| 02/04/1999 | WO1999004820A2 Cytolysis of target cells by superantigen conjugates inducing t-cell activation |
| 02/04/1999 | WO1999004813A1 Receptor specific transepithelial transport of therapeutics |
| 02/04/1999 | WO1999004810A2 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 02/04/1999 | WO1999004794A1 Cyclic amine modulators of chemokine receptor activity |
| 02/04/1999 | WO1998050424A3 Human serine protease precursor |
| 02/04/1999 | CA2732570A1 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 02/04/1999 | CA2298887A1 The ha-1 antigen |
| 02/04/1999 | CA2297923A1 Novel tetrazole-substituted 6-phenyl-pheanathridines as pde inhibitors |
| 02/04/1999 | CA2297910A1 Vitronectin receptor antagonist |
| 02/04/1999 | CA2297491A1 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 02/04/1999 | CA2296798A1 Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents |
| 02/04/1999 | CA2296314A1 Cyclic amine modulators of chemokine receptor activity |
| 02/04/1999 | CA2239267A1 Novel compounds |
| 02/03/1999 | EP0894863A1 A YAK-1 related serine/threonine protein kinase-HTLAR33 |
| 02/03/1999 | EP0894859A2 Asparaginyl tRNA synthetase from Streptococcus pneumoniae |
| 02/03/1999 | EP0894858A2 Prolyl tRNA synthetase from Streptococcus pneumoniae |
| 02/03/1999 | EP0894857A2 SecA gene from Streptococcus pneumoniae |
| 02/03/1999 | EP0894855A2 Human I kappa B-beta transcription factor |
| 02/03/1999 | EP0894854A2 A novel splicing variant of the epstein-barr virus-induced g-protein coupled receptor |
| 02/03/1999 | EP0894130A1 Modulators of tnf receptor associated factor (traf), their preparation and use |
| 02/03/1999 | EP0894006A1 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE THREONYL tRNA SYNTHETASE FAMILY |
| 02/03/1999 | EP0894001A1 Inhibitor of immunoglobulin e antibody production |
| 02/03/1999 | EP0893996A1 Use of rapamycin derivatives in vasculopathies and xenotransplantation |
| 02/03/1999 | EP0729352B1 Interdigitation-fusion liposomes containing arachidonic acid metabolites |
| 02/03/1999 | CN1207097A Novel substituted 4-(1H-benzimidazol-2-YL) [1,4] diazepanes useful for the treatment of allergic diseases |
| 02/03/1999 | CN1207044A Cyclosporin-containing soft capsule preparations |
| 02/03/1999 | CN1207042A A Pharmaceutical composition for the treatment of autommune diseases |
| 02/03/1999 | CN1041923C Piperzine derivatives and preparation process and usage thereof |
| 02/03/1999 | CN1041920C Glycerin derivative and its pharmacological use |
| 02/02/1999 | US5866717 Metalloproteinase inhibitors |
| 02/02/1999 | US5866703 With at least two different acids chosen from 6-desaturated essential fatty acids and oleic acid, useful in nutrition and in medicine. |
| 02/02/1999 | US5866616 3,3-(disubstituted) cyclohexan-1-ol monomers and related compounds |
| 02/02/1999 | US5866589 Alkyl substituted piperadinyl and piperazinyl anti-AIDS compounds |
| 02/02/1999 | US5866553 Immune protection against infection |
| 02/02/1999 | US5866390 Leucyl tRNA synthetase polynucleotides of streptococcus |
| 02/02/1999 | US5866373 Polynucleotide encoding a human chemotactic protein |
| 02/02/1999 | US5866160 Human therapy |
| 02/02/1999 | US5866157 Matrix patch formulation |
| 02/02/1999 | US5866140 Type I surface antigen associated with staphylococcus epidermidis |
| 02/02/1999 | US5866132 Immunogenic oligosaccharide compositions |
| 02/02/1999 | US5866129 Method of producing an antibody with a peptide corresponding to membrane-bound IgA |
| 02/02/1999 | US5866123 Gene encoding cationic amino acid transporter protein |
| 02/02/1999 | US5866115 Process for preparing dendritic cells, cells thus produced and containers for carrying out this process |
| 02/01/1999 | CA2238672A1 Seca |
| 01/29/1999 | CA2239266A1 Novel histidine kinase |
| 01/28/1999 | WO1999003995A1 T-cell receptor beta-like protein |
| 01/28/1999 | WO1999003991A1 Proteins mediating switch recombination |
| 01/28/1999 | WO1999003885A1 Antitumoral composition based on immunogenic polypeptide with modified cell location |